P Jacobsen, S Andersen, K Rossing, BR … - Kidney international, 2003 - nature.com Albuminuria and hypertension are predictors of poor renal and cardiovascular
outcome in diabetic patients. We tested whether dual blockade of the
renin-angiotensin system (RAS) with both an angiotensin-converting enzyme ... Cited by 194 - Related articles - BL Direct - All 4 versions
- Free from Publisher K Rossing, P Jacobsen, L Pietraszek, HH … - Diabetes Care, 2003 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—A total of 20 patients (17 men and 3 women) with
type 2 diabetes along with hypertension and nephropathy were enrolled in this
double-blind, randomized, two-period, crossover trial of 8 weeks of ... Cited by 169 - Related articles - BL Direct - All 6 versions
G Wolf, E Ritz - Kidney international, 2005 - nature.com Received 4 November 2003; Revised 23 December 2003; Re-revised 20 February 2004;
Re-revised 28 April 2004; Accepted 1 October 2004. ... Combination therapy with
ACE inhibitors and angiotensin II receptor blockers to halt progression of ... Cited by 156 - Related articles - All 3 versions
- ►asnjournals.org P Jacobsen, S Andersen, BR Jensen, HH … - Journal of the American Society of Nephrology, 2003 - Am Soc Nephrol Albuminuria and hypertension are predictors of poor renal and cardiovascular
outcome in patients with diabetes (1,2 ). Antihypertensive treatment, especially
ACE-I, has been shown to reduce albuminuria, to diminish loss of kidney ... Cited by 153 - Related articles - BL Direct - All 7 versions
R Campbell, F Sangalli, E Perticucci, C Aros, … - Kidney international, 2003 - nature.com In this prospective, randomized, cross-over study of 24 patients with
nondiabetic, chronic nephropathies, we compared the effects on proteinuria,
renal hemodynamics, and glomerular permselectivity of 8 weeks with ... Cited by 148 - Related articles - BL Direct - All 5 versions
- ►endojournals.org BF Schrijvers, AS De Vriese, A Flyvbjerg - Endocrine reviews, 2004 - Endocrine Soc At present, diabetic kidney disease affects about 15–25% of type 1 and
30–40% of type 2 diabetic patients. Several decades of extensive research has
elucidated various pathways to be implicated in the development of diabetic ... Cited by 120 - Related articles - All 5 versions
M MacKinnon, S Shurraw, A Akbari, GA Knoll, … - American Journal of Kidney Diseases, 2006 - Elsevier Blockade of the renin-angiotensin system with either an angiotensin-converting
enzyme (ACE) inhibitor or an angiotensin receptor blocker (ARB) was shown to
decrease urinary protein excretion and slow the progression of both ... Cited by 120 - Related articles - All 3 versions
- ►annals.org R Kunz, C Friedrich, M Wolbers, JFE Mann - Annals of Internal Medicine, 2007 - Am Coll Physicians This position paper concerns improving health care in the United States. Unlike
previous highly focused policy papers by the American College of Physicians,
this article takes a comprehensive approach to improving access, quality, ... Cited by 118 - Related articles - BL Direct - All 6 versions
UC Brewster, MA Perazella - The American journal of medicine, 2004 - Elsevier The renin-angiotensin-aldosterone system regulates renal vasomotor activity,
maintains optimal salt and water homeostasis, and controls tissue growth in the
kidney. However, pathologic consequences can result from overactivity of ... Cited by 108 - Related articles - All 8 versions
M Azizi, J Menard - Circulation, 2004 - Am Heart Assoc An ACE inhibitor administered at usual daily doses only suppresses plasma Ang II
levels within a few hours after dose intake, and similarly, usual daily doses of
an AT1R antagonist do not block AT1Rs over 24-hour periods. 18,19 This has ... Cited by 103 - Related articles - BL Direct - All 7 versions
